DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Orlowski RZ, Voorhees PM, Garcia RA. et al.
Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies.
Blood 2005; 105: 3058-3065
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.